Ventas (VTR) Misses Q2 EPS by 3c, Beats on Revenues; Reaffirms FY17 Guidance
Tweet
Share
E-mail
Get Alerts VTR Hot Sheet
Price: $86.96 --0%
Financial Fact:
Medical office building services revenue: 4.32M
Today's EPS Names:
SUNE, NSLR, OCTV, More
Financial Fact:
Medical office building services revenue: 4.32M
Today's EPS Names:
SUNE, NSLR, OCTV, More
Join SI Premium – FREE
Ventas (NYSE: VTR) reported Q2 EPS of $0.42, $0.03 worse than the analyst estimate of $0.45. Revenue for the quarter came in at $895.49 million versus the consensus estimate of $880.72 million.
GUIDANCE:
Ventas sees FY2017 EPS of $1.72-$1.78, versus the consensus of $1.81.
For earnings history and earnings-related data on Ventas (VTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nebius soars on second quarter revenue beat
- Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
- BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
